SMOFLipid in Patients Who Are Intralipid Intolerant

NCT03054948 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Redesign of study protocol.

Conditions

Home Parenteral Nutrition
Short Bowel Syndrome

Interventions

DRUG: SMOFLipid
DRUG: Standard therapy

Sponsor

Mayo Clinic